OBJECTIVE: The safety of a booster dose of a reduced-antigen-content tetanus–diphtheria–
acellular pertussis (Tdap) vaccine was evaluated in adolescents previously vaccinated with …

CHILDHOOD immunization against diphtheria-tetanus-pertussis using an acellular pertussis
vaccine for the first three doses has moved measurably closer. Data from two large field …

The objective of this study was to evaluate reactogenicity and immunogenicity of the recently
US-licensed Connaught/BIKEN (C/B) acellular DTP (ADTP) vaccine as a booster for children …

Objective: To assess the efficacy and safety of whole-cell and acellular pertussis vaccines
administered to children singly or within diphtheria, tetanus and pertussis (DTP) vaccines …

Healthy 17-to 24-month-old children, previously immunized with three doses of whole-cell
diphtheria-tetanus-pertussis (DTP) vaccine, were enrolled in a multicenter double-blind …

In a randomized double-blind trial 55 children of 15–24 months and 56 children of 4–6 years
of age previously immunized with whole-cell DTP (WC-DTP) received acellular pertussis …

Sustained high incidence of pertussis, particularly amongst unvaccinated infants, is of
concern. Inclusion of pertussis vaccination with tetanus and low dose diphtheria (Td) …

This review offers a perspective on the acellular pertussis vaccine efficiency trials concluded
in the 1990s and presents the main conclusions of a meta-analysis of 52 studies that …

Background: In a previous study, we found that monovalent acellular pertussis (aP) vaccine
at birth and 1 month achieves higher IgG antibody (Ab) levels to pertussis toxoid (PT) …

Objective. To evaluate the effect of maternally derived antibody on the immunogenicity and
reactogenicity of acellular (DTaP) or whole-cell (DTP) pertussis vaccine with diphtheria and …